Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Generic minoxidil receives FDA approval

April 16, 1997

Faulding launches wound care line in Australia and New Zealand

April 15, 1997

Merck & Co. prepares cytokine inhibitors

April 15, 1997

Scherer granted U.S. patent for ascorbic acid in softgel delivery system

April 14, 1997

Connetics commences phase III trial for betamethasone mousse

April 8, 1997

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

ProCyte reports results from hair growth trial

April 7, 1997

Pharmadigm's PB-OO5 enters phase II as burn treatment

April 2, 1997

ICOS initiates phase I with monoclonal antibody

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...